ENLV   $1.16  0.87% Market Open

Enlivex Therapeutics Ltd
Total Cash 25.94M
totalCashPerShare 1.242
EBITDA -17.89M
Total Debt 835.00K
quickRatio 9.574
currentRatio 10.056
Total Revenue
debtToEquity 2.923
Revenue/Share
ROA -0.27456
ROE -0.61166
grossProfits
freeCashflow -11.98M
operatingCashflow -17.02M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.73M
forwardPE -2.2155173
floatShares 15.60M
sharesOutstanding 21.41M
sharesShort 100.86K
sharesShortPriorMonth 136.13K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.17%
Short Ratio help_outline 0.96%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.368
Price To Book help_outline 0.94
earningsQuarterlyGrowth
netIncomeToCommon -22.29M
trailingEps -1.18%
forwardEps -0.58%
enterpriseToEbitda -0.10
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.18 3Q 2024
institutionsCount 22
lastUpdated Nov. 6, 2024, 5:26 p.m.